IO Biotech
Dawn C. C. is an accomplished executive administrative professional with extensive experience supporting C-suite executives across various industries. Currently serving as the Executive Assistant to the Chief Medical Officer and Chief Business Officer at IO Biotech, Dawn has previously held significant roles at Ovid Therapeutics, ASCEND CAPITAL GROUP, LLC, Samsung Electronics America, the University of Maryland, Baltimore, Camden Partners Holdings, LLC, and Johns Hopkins University, where responsibilities included managing complex administrative tasks, budgeting, coordinating recruitment processes, and overseeing office operations. Dawn holds a Bachelor's degree in Audiology and Speech-Language Pathology from Hampton University.
This person is not in any teams
This person is not in any offices
IO Biotech
2 followers
IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer. Their pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules.